Avita Medical Inc - Company Profile
Powered by
All the data and insights you need on Avita Medical Inc in one report.
- Save hours of research time and resources with
our up-to-date Avita Medical Inc Strategy Report
- Understand Avita Medical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. It develops products to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company’s lead product is RECELL System, a single use (disposable) stand-alone, battery operated device, which is approved for the treatment of acute thermal burns in adult patients; and also for treating vitiligo and full-thickness skin defects in the US. The company has operations in the US, Australia, Japan and the UK, besides the European Union. Avita Medical is headquartered in Valencia, California, the US.
Avita Medical Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
The RECELL Autologous Cell Harvesting System (RECELL System) | Spray-On Skin |
Spray Delivery of Single Living Cells for Epidermal Regeneration | RECELL |
Skin Grafting Techniques |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In January, the company entered into an agreement with Stedical Scientific, Inc. to facilitate the commercialization of PermeaDerm Biosynthetic Wound Matrix in the US. |
2023 | Contracts/Agreements | In November, the company entered into a distribution agreement with PolyMedics Innovations GmbH to strategically expand its global presence to Europe. |
2023 | Regulatory Approval | In June, the company received U.S. Food and Drug Administration approval for the use of its RECELL system to treat vitiligo. |
Competitor Comparison
Key Parameters | Avita Medical Inc | Johnson & Johnson | Smith & Nephew Plc | Organogenesis Holdings Inc | Vericel Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United Kingdom | United States of America | United States of America |
City | Valencia | New Brunswick | Watford | Canton | Cambridge |
State/Province | California | New Jersey | England | Massachusetts | Massachusetts |
No. of Employees | 207 | 131,900 | 19,000 | 1,030 | 305 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Lou Panaccio | Chairman | Executive Board | 2014 | 66 |
James Corbett | Director; Chief Executive Officer | Executive Board | 2022 | 65 |
David O’Toole | Chief Financial Officer | Senior Management | 2023 | 65 |
Niraj Doshi | Senior Vice President - Product Development & Program Management | Senior Management | - | - |
Debbie Garner | Senior Vice President - Global Marketing & Strategy | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer